Search Results - "Lamprecht, Donald G."

Clinical conundrums involving statin drug-drug interactions by Lamprecht, Donald G., Saseen, Joseph J., Shaw, Paul B.

“…Statins are the cornerstone of pharmacologic therapy for the prevention and treatment of atherosclerotic cardiovascular disease. While they are generally…”
Get full text

Pharmacist prescribing practices in a clinical pharmacy cardiac risk service by Todd, Brittany A, Lamprecht, Donald G, Stadler, Sheila L

“…PURPOSEPrescribing practices within a clinical pharmacy cardiac risk service (CPCRS) and their impact on treatment outcomes in patients with atherosclerotic…”
Get full text

Recommendations for Managing Drug–Drug Interactions with Statins and HIV Medications by Wiggins, Barbara S., Lamprecht, Donald G., Page, Robert L., Saseen, Joseph J.

“…The discovery of antiretroviral therapy (ART) for the treatment of human immunodeficiency virus (HIV) has enabled individuals to live longer. As a result, HIV…”
Get full text

Clinical Pharmacist Patient-Safety Initiative to Reduce Against-Label Prescribing of Statins With Cyclosporine by Lamprecht, Donald G., Todd, Brittany A., Denham, Anne M., Ruppe, Leslie K., Stadler, Sheila L.

“…Background: Against-label prescribing of statins with interacting drugs, such as cyclosporine, represents an important patient safety concern. Objective: To…”
Get full text

Trends in high-intensity statin use and low-density lipoprotein cholesterol control among patients enrolled in a clinical pharmacy cardiac risk service by Lamprecht, Donald G., Shaw, Paul B., King, Jordan B., Hogan, Keri N., Olson, Kari L.

“…Although high-intensity statin therapy (HIST) is recommended for most patients between 21 and 75 years of age with atherosclerotic cardiovascular disease…”
Get full text

A Clinical Pharmacist Patient-Centered Approach to Achieving Lipid Goals by Adding Controlled-Release Niacin to Moderate or High-Intensity Statin by Schwellenbach, Lisa J., PharmD, Lamprecht, Donald G., PharmD

Get full text

A Clinical Pharmacist Patient-Safety Initiative to Reduce Against-Label Prescribing of Statins with Cyclosporine by Lamprecht, Donald G., PharmD, Denham, Anne M., PharmD, Ruppe, Leslie K., PharmD, Stadler, Sheila L., PharmD, Todd, Brittany A., PharmD

Get full text

Complementary and Alternative Therapies for the Management of Dyslipidemia by Nies, Leslie K, Cymbala, Alicia A, Kasten, Sheila L, Lamprecht, Donald G, Olson, Kari L

“…Objective: To review the literature on select alternative therapies for the management of dyslipidemia. Data Sources: Searches of MEDLINE and PubMed…”
Get full text